ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -76.9% | 967 | -74.3% | 0.00% | – |
| Q1 2020 | $13,000 | -85.7% | 3,765 | -75.1% | 0.00% | – |
| Q4 2019 | $91,000 | -2.2% | 15,111 | +21.8% | 0.00% | – |
| Q3 2019 | $93,000 | -43.3% | 12,408 | +2.1% | 0.00% | – |
| Q2 2019 | $164,000 | +1950.0% | 12,156 | +402.1% | 0.00% | – |
| Q4 2018 | $8,000 | -60.0% | 2,421 | +0.9% | 0.00% | – |
| Q3 2018 | $20,000 | -97.3% | 2,400 | -96.8% | 0.00% | – |
| Q2 2018 | $730,000 | +4766.7% | 75,000 | +6017.5% | 0.00% | – |
| Q4 2017 | $15,000 | -97.9% | 1,226 | -98.6% | 0.00% | – |
| Q3 2017 | $710,000 | +23566.7% | 85,000 | +46095.7% | 0.00% | – |
| Q2 2017 | $3,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
| ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
| AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
| ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
| Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
| Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
| J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |